Symbolbild · KI-generiert
Prelude Therapeutics Incorporated
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Prelude Therapeutics is a clinical-stage biotechnology company developing cancer therapeutics that target epigenetic regulators. The focus is on inhibitors of proteins such as DCAF1 and EZH2, which are relevant in various haematological and solid tumours. The company is predominantly in the clinical development stage.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Prelude Therapeutics Incorporated | PRLD | NASDAQ | 366 Mio. USD |
| Enanta Pharmaceuticals, Inc. | ENTA | NASDAQ | 366 Mio. USD |
| Abeona Therapeutics Inc. | ABEO | NASDAQ | 366 Mio. USD |
| Century Therapeutics, Inc. | IPSC | NASDAQ | 364 Mio. USD |
| Tenax Therapeutics, Inc. | TENX | NASDAQ | 363 Mio. USD |
| Mobia Medical, Inc. | MOBI | NASDAQ | 372 Mio. USD |
| Emergent BioSolutions Inc. | EBS | NYSE | 373 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.